Table 1 Baseline socio-demographic and drug use characteristics of participants enrolled, lost to follow-up, and retained in the OSTPP in Kabul, Afghanistan
Characteristic | Total baseline participants (N = 83) | Lost to follow-up (N = 38) | Baseline participants retained by endline (N = 45) | p value |
|---|---|---|---|---|
n (%) | n (%) | n (%) | ||
Age (years) | ||||
18–24 | 13 (15.7) | 11 (29.0) | 2 (4.4) | <0.01 |
25–29 | 23 (27.7) | 10 (26.3) | 13 (28.9) | 0.77 |
30–34 | 17 (20.5) | 7 (18.4) | 10 (22.2) | 0.51 |
35+ | 30 (36.1) | 10 (26.3) | 20 (44.4) | 0.01 |
Marital statusa | ||||
Single | 43(51.8) | 14 (37.8) | 29 (64.4) | <0.01 |
Married/engaged | 37 (44.5) | 21 (56.8) | 16 (35.6) | |
Family contact in the past month | ||||
No contact | 21 (25.3) | 16 (42.1) | 5 (11.1) | <0.01 |
Less than daily | 16 (19.3) | 7 (18.4) | 9 (20.0) | |
Daily | 46 (55.4) | 15 (39.5) | 31 (68.9) | |
General health score mean (SD) (range: 1–10) | 5.1 (2.1) | 5.2 (2.4) | 5.0 (1.8) | 0.67 |
Mental health symptoms (range: 1–20) | ||||
Total number of symptoms, mean (SD) | 6.5 (3.7) | 6.7 (4.4) | 6.2 (2.9) | 0.62 |
Depressive symptoms mean(SD) | 4.3 (2.4) | 4.5 (2.5) | 4.1 (2.3) | 0.42 |
PTSD symptoms mean (SD) | 2.7 (1.6) | 1.2 (1.5) | 1.5 (1.6) | 0.34 |
Psychotic symptoms mean (SD) | 1.5 (1.4) | 1.3 (1.7) | 0.38 (1.1) | <0.01 |
Frequency of heroin useb | ||||
Once a week—less than daily | 1 (1.2) | 1 (2.6) | 0 (0) | 0.05 |
Daily | 79 (95.2) | 36 (94.7) | 43 (95.6) | |
No response | 3 (3.6) | 1 (2.6) | 2 (4.4) | |
Ever injected drugs | ||||
Yes (not in the past month) | 34 (41.0) | 15 (39.5) | 19 (42.2) | 0.67 |
Yes (past month) | 36 (43.4) | 15 (38.5) | 21 (46.7) | |
No response | 13 (15.7) | 8 (2.2) | 5 (2.2) | |
Age first heroin use mean (SD) | 22.8 (5.8) | 21.1 (5.3) | 24.4 (6.3) | 0.01 |
Ever treated for substance use | ||||
Yes | 62 (74.7) | 29 (76.3) | 33 (73.3) | 0.42 |
No | 19 (22.9) | 9 (23.7) | 10 (22.2) | |
No response | 2 (2.4) | 0 (0) | 2 (4.4) | |
Ever in prison | 43 (51.8) | 21 (55.3) | 22 (48.9) | 0.43 |
HIV positivec | 5 (6.0) | 2 (5.2) | 3 (6.6) | 0.59 |
HCV positivec | 50 (60.2) | 22 (57.9) | 28 (62.2) | 0.59 |